Associated Papers
Structural insights into human ELAC2 as a tRNA 3' processing enzyme.
Xue C et al.
Nucleic Acids Research, 2024
Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases.
Tan J et al.
Ebiomedicine, 2020
32305867 (PubMed )
Supplement: mmc3.xlsx › Excluded_variants
iFish: predicting the pathogenicity of human nonsynonymous variants using gene-specific/family-specific attributes and classifiers.
Wang M et al.
Scientific Reports, 2016
27527004 (PubMed )
Supplement: srep31321-s4.xls › SwissvarFilteredMix
DiMeX: A Text Mining System for Mutation-Disease Association Extraction.
Mahmood AS et al.
Plos One, 2016
[Hereditary prostate cancer].
Heise M et al.
Postepy Higieny I Medycyny Doswiadczalnej (online), 2014
Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway.
Lindström S et al.
The Prostate, 2006
Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma.
Noonan-Wheeler FC et al.
The Prostate, 2006
[Molecular basis of hereditary hemochromatosis].
Romanowski T et al.
Postepy Higieny I Medycyny Doswiadczalnej (online), 2006
Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
Rennert H et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2005
HPC2/ELAC2 gene variants associated with incident prostate cancer.
Adler D et al.
Journal of Human Genetics, 2003
HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease.
Meitz JC et al.
British Journal of Cancer, 2002
Perspective: prostate cancer susceptibility genes.
Simard J et al.
Endocrinology, 2002
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
Rökman A et al.
Cancer Research, 2001
Select a paper to view details